August 20, 2026 · earnings
COAG earnings: a negative outcome, -6.7%
On August 20, 2026, Hemab Therapeutics Holdings, Inc. reached its earnings. The result was a negative outcome, and the stock moved -6.7% in the window around the event. It had already run +11.0% in the 30 days into the catalyst — the kind of pre-event run-up that often precedes binary readouts.
The move
$51.66
1d before
$48.20
Event day
$49.16
1d after
$49.65
5d after
Our prediction vs. the result
CatalystAlert called this one neutral (+3.0% expected); the stock actually moved -6.7%. Model confidence at the time: 65%.
See the full scored track recordPre-catalyst setup
+11.0%
30-day run-up
6808%
30-day volatility
0.7×
volume spike